Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1110292
Abstract: Human leukocyte antigen (HLA) molecular mismatch is a powerful biomarker of rejection. Few studies have explored its use in assessing rejection risk in heart transplant recipients. We tested the hypothesis that a combination of HLA… read more here.
Keywords: pirche; risk; transplant; hla emma ... See more keywords